‘Consider all evidences, including trial flop, before approving remdesivir’
Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidences, including a trial in which the medicine failed, before giving it the green light, the top WHO...
সম্পূর্ণ আর্টিকেলটি পড়ুন
We use cookies to ensure you get the best experience on our website.